Syprine (Valeant Pharmaceuticals North America LLC)
Welcome to the PulseAid listing for the Syprine drug offered from Valeant Pharmaceuticals North America LLC. This Metal Chelating Activity [MoA],Metal Chelator [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Valeant Pharmaceuticals North America LLC |
NON-PROPRIETARY NAME: | trientine hydrochloride |
SUBSTANCE NAME: | TRIENTINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Metal Chelating Activity [MoA],Metal Chelator [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1985-11-08 |
END MARKETING DATE: | 0000-00-00 |
Syprine HUMAN PRESCRIPTION DRUG Details:
Item Description | Syprine from Valeant Pharmaceuticals North America LLC |
LABELER NAME: | Valeant Pharmaceuticals North America LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250(mg/1) |
START MARKETING DATE: | 1985-11-08 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0187-2120_1573b87f-4dab-4a45-9cbb-9cbf9d8c7321 |
PRODUCT NDC: | 0187-2120 |
APPLICATION NUMBER: | NDA019194 |
Other TRIENTINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: